MeSH Review:
Combined Modality Therapy
Garcia del Muro,
Condom,
Vigués,
Castellsagué,
Figueras,
Muñoz,
Solá,
Soler,
Capellà,
Germà,
Albert,
Tempany,
Schultz,
Chen,
Cormack,
Kumar,
Hurwitz,
Beard,
Tuncali,
O'Leary,
Topulos,
Valentine,
Lopes,
Kanan,
Kacher,
Rosato,
Kooy,
Jolesz,
Carr-Locke,
Richie,
D'Amico,
Sersa,
Kranjc,
Cemazar,
Barkley,
Yano,
Tsujinaka,
Shiozaki,
Inoue,
Doki,
Yamamoto,
Tanaka,
Inoue,
Monden,
Girinsky,
Pichenot,
Beaudre,
Ghalibafian,
Lefkopoulos,
Bondar,
Rago,
Cottone,
Wilkerson,
Riggs,
Sarbia,
Stahl,
von Weyhern,
Weirich,
Pühringer-Oppermann,
Chakravarti,
Chakladar,
Delaney,
Latham,
Loeffler,
Brewerton,
Schorge,
Lee,
Lee,
Flynn,
Goodman,
Sheets,
Cooper,
Guo,
Herskovic,
Macdonald,
Martenson,
Al-Sarraf,
Byhardt,
Russell,
Beitler,
Spencer,
Asbell,
Graham,
Leichman,
Minsky,
- Phase I trial of combined-modality therapy for localized esophageal cancer: escalating doses of continuous-infusion paclitaxel with cisplatin and concurrent radiation therapy. Brenner, B., Ilson, D.H., Minsky, B.D., Bains, M.S., Tong, W., Gonen, M., Kelsen, D.P. J. Clin. Oncol. (2004)
- Phase III randomized intergroup trial of subtotal lymphoid irradiation versus doxorubicin, vinblastine, and subtotal lymphoid irradiation for stage IA to IIA Hodgkin's disease. Press, O.W., LeBlanc, M., Lichter, A.S., Grogan, T.M., Unger, J.M., Wasserman, T.H., Gaynor, E.R., Peterson, B.A., Miller, T.P., Fisher, R.I. J. Clin. Oncol. (2001)
- Long-term follow-up for locally advanced and inflammatory breast cancer patients treated with multimodality therapy. Low, J.A., Berman, A.W., Steinberg, S.M., Danforth, D.N., Lippman, M.E., Swain, S.M. J. Clin. Oncol. (2004)
- The epidermal growth factor receptor pathway mediates resistance to sequential administration of radiation and chemotherapy in primary human glioblastoma cells in a RAS-dependent manner. Chakravarti, A., Chakladar, A., Delaney, M.A., Latham, D.E., Loeffler, J.S. Cancer Res. (2002)
- Prognostic significance of cyclin D1 in esophageal squamous cell carcinoma patients treated with surgery alone or combined therapy modalities. Sarbia, M., Stahl, M., Fink, U., Heep, H., Dutkowski, P., Willers, R., Seeber, S., Gabbert, H.E. Int. J. Cancer (1999)
- Case study: fluoxetine in the multimodal treatment of a preschool child with selective mutism. Wright, H.H., Cuccaro, M.L., Leonhardt, T.V., Kendall, D.F., Anderson, J.H. Journal of the American Academy of Child and Adolescent Psychiatry. (1995)
- Late genitourinary and gastrointestinal toxicity after magnetic resonance image-guided prostate brachytherapy with or without neoadjuvant external beam radiation therapy. Albert, M., Tempany, C.M., Schultz, D., Chen, M.H., Cormack, R.A., Kumar, S., Hurwitz, M.D., Beard, C., Tuncali, K., O'Leary, M., Topulos, G.P., Valentine, K., Lopes, L., Kanan, A., Kacher, D., Rosato, J., Kooy, H., Jolesz, F., Carr-Locke, D.L., Richie, J.P., D'Amico, A.V. Cancer (2003)
- Improvement in psychological functioning among drug abusers: inpatient treatment compared to outpatient methadone maintenance. Craig, R.J., Olson, R., Shalton, G. Journal of substance abuse treatment. (1990)
- Chemical aversion therapy in the treatment of cocaine dependence as part of a multimodal treatment program: treatment outcome. Frawley, P.J., Smith, J.W. Journal of substance abuse treatment. (1990)
- Commentary on the multimodal treatment study of children with ADHD. Barkley, R.A. Journal of abnormal child psychology. (2000)
- Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. Cooper, J.S., Guo, M.D., Herskovic, A., Macdonald, J.S., Martenson, J.A., Al-Sarraf, M., Byhardt, R., Russell, A.H., Beitler, J.J., Spencer, S., Asbell, S.O., Graham, M.V., Leichman, L.L. JAMA (1999)
- A multidisciplinary approach to therapy for unresectable malignant thymoma. Shin, D.M., Walsh, G.L., Komaki, R., Putnam, J.B., Nesbitt, J., Ro, J.Y., Shin, H.J., Ki, K.H., Wimberly, A., Pisters, K.M., Schrump, D., Gregurich, M.A., Cox, J.D., Roth, J.A., Hong, W.K. Ann. Intern. Med. (1998)
- Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer. A randomized, phase III trial. Morton, R.F., Jett, J.R., McGinnis, W.L., Earle, J.D., Therneau, T.M., Krook, J.E., Elliott, T.E., Mailliard, J.A., Nelimark, R.A., Maksymiuk, A.W. Ann. Intern. Med. (1991)
- Telomerase-dependent virotherapy overcomes resistance of hepatocellular carcinomas against chemotherapy and tumor necrosis factor-related apoptosis-inducing ligand by elimination of Mcl-1. Wirth, T., Kühnel, F., Fleischmann-Mundt, B., Woller, N., Djojosubroto, M., Rudolph, K.L., Manns, M., Zender, L., Kubicka, S. Cancer Res. (2005)
- Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group. Murray, N., Coy, P., Pater, J.L., Hodson, I., Arnold, A., Zee, B.C., Payne, D., Kostashuk, E.C., Evans, W.K., Dixon, P. J. Clin. Oncol. (1993)
- Incorporation of paclitaxel and carboplatin in combined-modality therapy for locally advanced non-small cell lung cancer. Belani, C.P. Semin. Oncol. (1999)
- Oxaliplatin-based combined-modality therapy for rectal cancer. Minsky, B.D. Semin. Oncol. (2003)
- Is intensity-modulated radiotherapy better than conventional radiation treatment and three-dimensional conformal radiotherapy for mediastinal masses in patients with Hodgkin's disease, and is there a role for beam orientation optimization and dose constraints assigned to virtual volumes? Girinsky, T., Pichenot, C., Beaudre, A., Ghalibafian, M., Lefkopoulos, D. Int. J. Radiat. Oncol. Biol. Phys. (2006)
- The combined modality therapy of diffuse histology non-Hodgkin's lymphoma with cyclophosphamide, adriamycin, vincristine, prednisone (CHOP) and total body irradiation. Weick, J.K., Antunez, A., Kraus, T.A., Fabian, C.J., Dixon, D. Int. J. Radiat. Oncol. Biol. Phys. (1983)
- Curative radiotherapy following chemotherapy for invasive bladder carcinoma (a preliminary report). Farah, R., Chodak, G.W., Vogelzang, N.J., Awan, A.M., Quiet, C.A., Moormeier, J., Schoenberg, H., Weichselbaum, R.R. Int. J. Radiat. Oncol. Biol. Phys. (1991)
- The prognostic significance of genetic polymorphisms (Methylenetetrahydrofolate Reductase C677T, Methionine Synthase A2756G, Thymidilate Synthase tandem repeat polymorphism) in multimodally treated oesophageal squamous cell carcinoma. Sarbia, M., Stahl, M., von Weyhern, C., Weirich, G., Pühringer-Oppermann, F. Br. J. Cancer (2006)
- Pharmacokinetics of cisplatin in patients receiving interleukin-2-containing treatment regimens. Gandara, D.R., Perez, E.A., Denham, A., Wiebe, V.J., DeGregorio, M.W. Cancer Chemother. Pharmacol. (1989)
- Pilot study of local hyperthermia, radiation therapy, etanidazole, and cisplatin for advanced superficial tumours. Bornstein, B.A., Herman, T.S., Hansen, J.L., Buswell, L., Zouranjian, P.S., Fraser, S.M., Teicher, B.A., Svensson, G.K., Coleman, C.N. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. (1995)
- Academy of eating disorders international conference. Brewerton, T.D. Expert opinion on investigational drugs. (2004)
- Concurrent chemotherapy (5-fluorouracil and cisplatin) and radiation therapy followed by surgery for T4 squamous cell carcinoma of the esophagus. Yano, M., Tsujinaka, T., Shiozaki, H., Inoue, M., Doki, Y., Yamamoto, M., Tanaka, E., Inoue, T., Monden, M. Journal of surgical oncology. (1999)
- Unusual thoracic radiographic findings in children treated for Hodgkin's disease. Jochelson, M.S., Tarbell, N.J., Weinstein, H.J. J. Clin. Oncol. (1986)
- Combined modality therapy of lung cancer. Livingston, R.B. Clin. Cancer Res. (1997)
- UFT plus oral leucovorin calcium (Orzel) and radiation in combined modality therapy: a comprehensive review. Minsky, B.D. Int. J. Cancer (2001)
- Radiation and simultaneous cisplatin in non-small cell lung cancer. Bonomi, P. Int. J. Radiat. Oncol. Biol. Phys. (1993)
- One-hour paclitaxel in the treatment of non-small cell lung cancer. Hainsworth, J.D., Greco, F.A. Semin. Oncol. (1996)
- Neuroendocrine gastrointestinal tumors--a condensed overview of diagnosis and treatment. Oberg, K. Ann. Oncol. (1999)
- Cyclooxygenase-2 inhibition in colorectal cancer: boom or bust? Sanborn, R., Blanke, C.D. Semin. Oncol. (2005)
- Molecular strategies targeting the host component of cancer to enhance tumor response to radiation therapy. Kim, D.W., Huamani, J., Fu, A., Hallahan, D.E. Int. J. Radiat. Oncol. Biol. Phys. (2006)
- Combined modality therapy of A431 human epidermoid cancer using anti-EGFr antibody C225 and radiation. Saleh, M.N., Raisch, K.P., Stackhouse, M.A., Grizzle, W.E., Bonner, J.A., Mayo, M.S., Kim, H.G., Meredith, R.F., Wheeler, R.H., Buchsbaum, D.J. Cancer Biother. Radiopharm. (1999)
- p53 and p21 Expression levels predict organ preservation and survival in invasive bladder carcinoma treated with a combined-modality approach. Garcia del Muro, X., Condom, E., Vigués, F., Castellsagué, X., Figueras, A., Muñoz, J., Solá, J., Soler, T., Capellà, G., Germà, J.R. Cancer (2004)
- Enhancement of radiation-induced cell kill by platinum complexes (carboplatin and iproplatin) in V79 cells. O'Hara, J.A., Douple, E.B., Richmond, R.C. Int. J. Radiat. Oncol. Biol. Phys. (1986)
- Improvement of combined modality therapy with cisplatin and radiation using electroporation of tumors. Sersa, G., Kranjc, S., Cemazar, M. Int. J. Radiat. Oncol. Biol. Phys. (2000)
- Treatment selection for stage IIIA Hodgkin's disease patients. Prosnitz, L.R., Cooper, D., Cox, E.B., Kapp, D.S., Farber, L.R. Int. J. Radiat. Oncol. Biol. Phys. (1985)
- Early cervical adenocarcinoma: selection criteria for radical surgery. Schorge, J.O., Lee, K.R., Lee, S.J., Flynn, C.E., Goodman, A., Sheets, E.E. Obstetrics and gynecology. (1999)
- Chlorhexidine lavage in the treatment of experimental intra-abdominal infection. Bondar, V.M., Rago, C., Cottone, F.J., Wilkerson, D.K., Riggs, J. Archives of surgery (Chicago, Ill. : 1960) (2000)